Matching articles for "Levoxyl"

Drugs for Hypothyroidism

   
The Medical Letter on Drugs and Therapeutics • February 20, 2023;  (Issue 1670)
Primary hypothyroidism is usually the result of Hashimoto's (autoimmune) thyroiditis, thyroidectomy, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is...
Primary hypothyroidism is usually the result of Hashimoto's (autoimmune) thyroiditis, thyroidectomy, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is usually lifelong. Levothyroxine (LT4; synthetic thyroxine; Synthroid, and others) is the drug of choice.1
Med Lett Drugs Ther. 2023 Feb 20;65(1670):25-9 | Show Full IntroductionHide Full Introduction

Addendum: Timing of Levothyroxine

   
The Medical Letter on Drugs and Therapeutics • February 1, 2016;  (Issue 1487)
In our October 26, 2015 article on drugs for hypothyroidism (Med Lett Drugs Ther 2015; 57:147), we said that levothyroxine should be taken on an empty stomach with a full glass of water 30-60 minutes (60 is...
In our October 26, 2015 article on drugs for hypothyroidism (Med Lett Drugs Ther 2015; 57:147), we said that levothyroxine should be taken on an empty stomach with a full glass of water 30-60 minutes (60 is preferable) before breakfast. We should have added that taking the drug consistently at bedtime, at least 3 hours after the last meal, is an alternative that some patients may find more convenient.
Med Lett Drugs Ther. 2016 Feb 1;58(1487):18 | Show Full IntroductionHide Full Introduction

Drugs for Hypothyroidism

   
The Medical Letter on Drugs and Therapeutics • October 26, 2015;  (Issue 1480)
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is...
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is usually lifelong. Levothyroxine is the drug of choice.
Med Lett Drugs Ther. 2015 Oct 26;57(1480):147-50 | Show Full IntroductionHide Full Introduction

Drugs for Thyroid Disorders

   
The Medical Letter on Drugs and Therapeutics • August 1, 2009;  (Issue 84)
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism, goiter or cancer, or radioactive iodine therapy for...
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism, goiter or cancer, or radioactive iodine therapy for hyperthyroidism.
Treat Guidel Med Lett. 2009 Aug;7(84):57-64 | Show Full IntroductionHide Full Introduction

Drugs for Hypothyroidism and Hyperthyroidism

   
The Medical Letter on Drugs and Therapeutics • April 1, 2006;  (Issue 44)
Hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism or cancer, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone...
Hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism or cancer, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is usually lifelong. The drug of choice for thyroid replacement therapy is levothyroxine. Liothyronine and dessicated porcine thyroid are also marketed for this indication.
Treat Guidel Med Lett. 2006 Apr;4(44):17-24 | Show Full IntroductionHide Full Introduction

Generic Levothyroxine

   
The Medical Letter on Drugs and Therapeutics • September 20, 2004;  (Issue 1192)
The FDA has determined that 3 generic formulations of levothyroxine are therapeutically equivalent to brand-name formulations. Some brand-name manufacturers have objected, and endocrine organizations have...
The FDA has determined that 3 generic formulations of levothyroxine are therapeutically equivalent to brand-name formulations. Some brand-name manufacturers have objected, and endocrine organizations have expressed their concern.
See levothyroxine addendum
Med Lett Drugs Ther. 2004 Sep 20;46(1192):77-8 | Show Full IntroductionHide Full Introduction

What is Going on with Levothyroxine

   
The Medical Letter on Drugs and Therapeutics • July 9, 2001;  (Issue 1108)
The media recently reported that the FDA has threatened to withdraw Synthroid from the market, alarming many physicians and...
The media recently reported that the FDA has threatened to withdraw Synthroid from the market, alarming many physicians and patients.
Med Lett Drugs Ther. 2001 Jul 9;43(1108):57-8 | Show Full IntroductionHide Full Introduction